Armin Rath

Company: Cytovia Therapeutics

Job title: Head of New Product Development & R&D Alliances

Seminars:

Enhancing the Cytotoxic Anti-Tumor Activity of iNK Cell Therapy Using a Flex-NK™ Cell Engager 4:00 pm

Flex NK Cell Engager antibodies redirect NK cells to kill target tumor cells Flex NK cell Engager antibodies enhance the cytotoxicity of PBNK cells as well as iPSC derived NK cells (iNKs) Pre-clinical data supports initiation of clinical trials in both hematological malignancies and solid tumorsRead more

day: Day 1 Track 1 PM